<p>Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats</p>

Nur Samsu; Setyawati Soeharto; Muhaimin Rifai; Achmad Rudijanto

doi:10.2147/BTT.S214820

open access to scientific and medical research

Back to Journals » Biologics: Targets and Therapy » Volume 13

Original Research

Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats

Total article views		HTML views	PDF downloads	Totals
4,619	Dovepress*	4,133+	949	5,082
	PubMed Central*	486	148	634
	Totals	4,619	1,097	5,716
*Since 30 August 2019

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.